APO Research, Inc.

Cell Freezing Media Industry Research Report 2026

Choose your research edition.

Compare the research focus and single-user price for each edition.
Research editionIndustry ResearchSelectedIndustry Growth & TrendsMarket StructureMarket Outlook & Growth OpportunitiesMarket Analysis & Forecast
Core differenceUnderstand the overall industry landscape, competition and leading companies.Examine growth drivers and how demand is developing across regional markets.Compare how the market is divided across companies, types and applications.Compare regional and country-level demand to assess geographic market opportunities.Assess market size, historical trends and forecasts for forward planning.
Single-user price$2,950 USD$3,450 USD$3,950 USD$4,250 USD$4,950 USD
Your choiceCurrent editionView editionView editionView editionView edition
View pricing & licenses

Cell Freezing Media are formulated aqueous cryopreservation preparations used to preserve the viability, structural integrity, biological characteristics, and functional recovery of living cells during controlled freezing, cryogenic storage, and subsequent thawing. Their protective mechanisms address the physical and biochemical stresses associated with extracellular ice formation, progressive solute concentration, osmotic dehydration, intracellular ice formation, membrane destabilization, and freezing induced cellular injury. Commercial formulations typically combine a buffered aqueous medium with permeating cryoprotective agents, nonpermeating osmolytes, electrolytes, carbohydrates, and selected macromolecular stabilizers. Dimethyl sulfoxide (DMSO) is the predominant permeating cryoprotectant in established commercial formulations, commonly incorporated at concentrations of 2% to 10%, depending on the cell type and intended freezing conditions. DMSO modifies the freezing behavior of intracellular and extracellular water and reduces ice associated cellular damage, while its concentration and exposure conditions must be balanced against cytotoxicity and osmotic stress. Commercial DMSO free formulations employ alternative cryoprotective systems, including combinations of polyols, sugars, polymers, and other stabilizing constituents. Serum containing, serum free, protein free, animal component free, and chemically defined formulations represent different compositional specifications within these product families. The physical products are predominantly sterile liquid preparations supplied as ready for use solutions or concentrated formulations in bottles, vials, and flexible bags, with manufacturing involving controlled formulation, dissolution, filtration, and aseptic filling. Product specifications vary with cell membrane permeability, sensitivity to cryoprotectants, required post thaw recovery, and subsequent biological functionality. Commercial applications include the cryopreservation of established mammalian cell lines, primary cells, hematopoietic cells, immune cells, mesenchymal stromal cells, embryonic stem cells, induced pluripotent stem cells, and selected multicellular cultures. These products are consumed in laboratory research, biological sample repositories, master and working cell bank preparation for biopharmaceutical manufacturing, and the preservation of cellular intermediates and final cell preparations used in cell therapy and regenerative medicine. Commercial supply encompasses formulated freezing media for research and industrial cell processing, including specialized preparations manufactured for clinical cell processing and therapeutic manufacturing.

Product & engineering

Understand the product.

Cell Freezing Media are formulated aqueous cryopreservation preparations used to preserve the viability, structural integrity, biological characteristics, and functional recovery of living cells during controlled freezing, cryogenic storage, and subsequent thawing. Their protective mechanisms address the physical and biochemical stresses associated with extracellular ice formation, progressive solute concentration, osmotic dehydration, intracellular ice formation, membrane destabilization, and freezing induced cellular injury. Commercial formulations typically combine a buffered aqueous medium with permeating cryoprotective agents, nonpermeating osmolytes, electrolytes, carbohydrates, and selected macromolecular stabilizers. Dimethyl sulfoxide (DMSO) is the predominant permeating cryoprotectant in established commercial formulations, commonly incorporated at concentrations of 2% to 10%, depending on the cell type and intended freezing conditions. DMSO modifies the freezing behavior of intracellular and extracellular water and reduces ice associated cellular damage, while its concentration and exposure conditions must be balanced against cytotoxicity and osmotic stress. Commercial DMSO free formulations employ alternative cryoprotective systems, including combinations of polyols, sugars, polymers, and other stabilizing constituents. Serum containing, serum free, protein free, animal component free, and chemically defined formulations represent different compositional specifications within these product families. The physical products are predominantly sterile liquid preparations supplied as ready for use solutions or concentrated formulations in bottles, vials, and flexible bags, with manufacturing involving controlled formulation, dissolution, filtration, and aseptic filling. Product specifications vary with cell membrane permeability, sensitivity to cryoprotectants, required post thaw recovery, and subsequent biological functionality. Commercial applications include the cryopreservation of established mammalian cell lines, primary cells, hematopoietic cells, immune cells, mesenchymal stromal cells, embryonic stem cells, induced pluripotent stem cells, and selected multicellular cultures. These products are consumed in laboratory research, biological sample repositories, master and working cell bank preparation for biopharmaceutical manufacturing, and the preservation of cellular intermediates and final cell preparations used in cell therapy and regenerative medicine. Commercial supply encompasses formulated freezing media for research and industrial cell processing, including specialized preparations manufactured for clinical cell processing and therapeutic manufacturing.

Selected research

Industry Research

Cell Freezing Media Industry Research Report 2026

MARKET AT A GLANCE

Scale & outlook

2025
279.46USD million
2032
568.98USD million
Market size · USD million
03006002025 · 279.46 USD million279.4620252026 · 310.86 USD million310.8620262032 · 568.98 USD million568.982032

Select a bar to inspect its value.

Source: APO Research, Inc.

Market perspective

According to APO Research, Inc, the global Cell Freezing Media market was valued at USD 279.46 million in 2025, is estimated to reach USD 310.86 million in 2026, and is projected to increase to USD 568.98 million by 2032, representing a compound annual growth rate (CAGR) of 10.60% from 2026 to 2032. Market expansion is primarily associated with increasing commercial cell therapy production, greater utilization of formulated cryopreservation media in biopharmaceutical cell banking, and the adoption of specialized formulations for clinically manufactured cellular products. Cell therapy manufacturing generates recurring demand through cell collection, expansion, intermediate freezing, and final product filling, with consumption determined by processed cell volumes, manufacturing batch frequency, and the amount of freezing medium required per cell preparation. Biopharmaceutical manufacturing uses these products for master and working cell banks, where demand is associated with new production cell lines, manufacturing process development, and periodic bank replenishment. Research laboratories and biorepositories contribute additional consumption as new cell lines and biological specimens enter storage, although established frozen inventories require limited additional freezing medium.

The commercialization of cell therapies has established a significant source of demand for qualified cryopreservation formulations, particularly in the United States. BioLife Solutions reported revenue of USD 96.2 million in 2025, with its CryoStor product family accounting for 82% of the total. The company's biopreservation media revenue increased by USD 19.3 million, or 30%, during 2025, primarily reflecting higher demand from customers with commercially approved therapies. As of June 30, 2026, BioLife reported that its biopreservation media were incorporated into 18 commercial cell and gene therapies and approximately 250 ongoing commercially sponsored clinical trials in the United States. Repligen completed its acquisition of BioLife in October 2026, consolidating an established clinical cryopreservation media business with its bioprocessing operations. Clinical adoption establishes formulation specific requirements for cell viability, recovery, residual cryoprotectant exposure, and manufacturing consistency. Once incorporated into a validated therapeutic manufacturing process, changes to freezing media can require additional compatibility studies and process qualification, influencing supplier continuity and the commercial value of established formulations.

DMSO containing media remain widely used for routine cell banking and the preservation of established mammalian cell lines, stem cells, and immune cells. Sartorius supplies NutriFreez D10 and D5 formulations containing 10% and 5% DMSO, respectively, addressing different cell preservation and clinical processing requirements. FUJIFILM offers PRIME XV FreezIS formulations with and without DMSO, including products intended for further therapeutic manufacturing. In China, Yocon Biotechnology supplies GMP grade DMSO free freezing media for mesenchymal stem cells and other cellular preparations, while Japan's ZENOGEN PHARMA supplies both conventional and DMSO free CELLBANKER formulations. The development of chemically defined, serum free, and animal component free products reflects the requirements of clinical manufacturing processes for controlled raw material composition and reproducible post thaw cell performance. Revenue growth is expected to derive principally from higher commercial consumption and a changing mix of research and clinical formulations. Realized selling prices remain dependent on formulation complexity, aseptic manufacturing requirements, packaging configurations, customer qualification requirements, and procurement volumes. Competition from established international manufacturers and regional suppliers is expected to constrain price increases in conventional formulations, while specialized products retain differentiated pricing based on their manufacturing specifications and approved customer applications.

Full market overview

Report Scope

This report quantifies the global Cell Freezing Media market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cell Freezing Media Market by Company

  • Thermo Fisher Scientific
  • Merck
  • Cytiva
  • Sartorius
  • FUJIFILM
  • BioLife Solutions
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Bio Techne
  • Avantor
  • HiMedia Laboratories
  • ZENOAQ
  • PAN Biotech
  • PromoCell
  • MP Biomedicals
  • ATCC
  • Teknova
  • Yocon Biotechnology
  • ExCell Bio
  • Shanghai BasalMedia
  • Dakewe
  • Cyagen Biosciences
  • Yeasen Biotechnology
  • Solarbio
  • Beyotime Biotechnology
  • Quality Biological
  • WELGENE
  • GC Lymphotec
  • Capricorn Scientific
  • Meilun Biotechnology
  • Nacalai Tesque
  • Saraya
  • ScienCell Research Laboratories
  • Cell Applications
  • Nanjing Sansheng Biotechnology
  • Pricella Biotechnology
  • CELLnTEC

Cell Freezing Media Segment by Type

  • DMSO Containing
  • DMSO Free

Cell Freezing Media Segment by Application

  • Research
  • Biobanking
  • Biopharmaceutical Manufacturing
  • Cell Therapy and Regenerative Medicine

Cell Freezing Media Segment by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Poland
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Southeast Asia
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Türkiye
    • GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

  1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Freezing Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  2. This report will help stakeholders to understand the global industry status and trends of Cell Freezing Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
  3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  4. This report stays updated with novel technology integration, features, and the latest developments in the market
  5. This report helps stakeholders to gain insights into which regions to target globally
  6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Freezing Media.
  7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

  1. Chapter 1: Research objectives, research methods, data sources, data cross-validation;
  2. Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  3. Chapter 3: Detailed analysis of Cell Freezing Media manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  4. Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  5. Chapter 5: Production/output, value of Cell Freezing Media by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  6. Chapter 6: Consumption of Cell Freezing Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  7. Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  8. Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  9. Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
  10. Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  11. Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures

List of Tables

  • Table 1. Secondary Sources
  • Table 2. Primary Sources
  • Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  • Table 5. Global Cell Freezing Media Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
  • Table 6. Global Cell Freezing Media Sales (L) of Manufacturers (2021-2026)
  • Table 7. Global Cell Freezing Media Sales Market Share by Manufacturers (2021-2026)
  • Table 8. Global Cell Freezing Media Revenue of Manufacturers (2021-2026)
  • Table 9. Global Cell Freezing Media Revenue Share by Manufacturers (2021-2026)
  • Table 10. Global Market Cell Freezing Media Average Price (USD/L) of Manufacturers (2021-2026)
  • Table 11. Global Cell Freezing Media Industry Ranking, 2024 VS 2025 VS 2026
  • Table 12. Global Manufacturers of Cell Freezing Media, Manufacturing Sites & Headquarters
  • Table 13. Global Manufacturers of Cell Freezing Media, Product Type & Application
  • Table 14. Global Cell Freezing Media Manufacturers Established Date
  • Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 16. Global Cell Freezing Media by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
  • Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
  • Table 18. Thermo Fisher Scientific Company Information
  • Table 19. Thermo Fisher Scientific Business Overview
  • Table 20. Thermo Fisher Scientific Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 21. Thermo Fisher Scientific Cell Freezing Media Product Portfolio
  • Table 22. Thermo Fisher Scientific Recent Developments
  • Table 23. Merck Company Information
  • Table 24. Merck Business Overview
  • Table 25. Merck Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 26. Merck Cell Freezing Media Product Portfolio
  • Table 27. Merck Recent Developments
  • Table 28. Cytiva Company Information
  • Table 29. Cytiva Business Overview
  • Table 30. Cytiva Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 31. Cytiva Cell Freezing Media Product Portfolio
  • Table 32. Cytiva Recent Developments
  • Table 33. Sartorius Company Information
  • Table 34. Sartorius Business Overview
  • Table 35. Sartorius Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 36. Sartorius Cell Freezing Media Product Portfolio
  • Table 37. Sartorius Recent Developments
  • Table 38. FUJIFILM Company Information
  • Table 39. FUJIFILM Business Overview
  • Table 40. FUJIFILM Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 41. FUJIFILM Cell Freezing Media Product Portfolio
  • Table 42. FUJIFILM Recent Developments
  • Table 43. BioLife Solutions Company Information
  • Table 44. BioLife Solutions Business Overview
  • Table 45. BioLife Solutions Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 46. BioLife Solutions Cell Freezing Media Product Portfolio
  • Table 47. BioLife Solutions Recent Developments
  • Table 48. Lonza Company Information
  • Table 49. Lonza Business Overview
  • Table 50. Lonza Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 51. Lonza Cell Freezing Media Product Portfolio
  • Table 52. Lonza Recent Developments
  • Table 53. STEMCELL Technologies Company Information
  • Table 54. STEMCELL Technologies Business Overview
  • Table 55. STEMCELL Technologies Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 56. STEMCELL Technologies Cell Freezing Media Product Portfolio
  • Table 57. STEMCELL Technologies Recent Developments
  • Table 58. Miltenyi Biotec Company Information
  • Table 59. Miltenyi Biotec Business Overview
  • Table 60. Miltenyi Biotec Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 61. Miltenyi Biotec Cell Freezing Media Product Portfolio
  • Table 62. Miltenyi Biotec Recent Developments
  • Table 63. Bio Techne Company Information
  • Table 64. Bio Techne Business Overview
  • Table 65. Bio Techne Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 66. Bio Techne Cell Freezing Media Product Portfolio
  • Table 67. Bio Techne Recent Developments
  • Table 68. Avantor Company Information
  • Table 69. Avantor Business Overview
  • Table 70. Avantor Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 71. Avantor Cell Freezing Media Product Portfolio
  • Table 72. Avantor Recent Developments
  • Table 73. HiMedia Laboratories Company Information
  • Table 74. HiMedia Laboratories Business Overview
  • Table 75. HiMedia Laboratories Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 76. HiMedia Laboratories Cell Freezing Media Product Portfolio
  • Table 77. HiMedia Laboratories Recent Developments
  • Table 78. ZENOAQ Company Information
  • Table 79. ZENOAQ Business Overview
  • Table 80. ZENOAQ Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 81. ZENOAQ Cell Freezing Media Product Portfolio
  • Table 82. ZENOAQ Recent Developments
  • Table 83. PAN Biotech Company Information
  • Table 84. PAN Biotech Business Overview
  • Table 85. PAN Biotech Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 86. PAN Biotech Cell Freezing Media Product Portfolio
  • Table 87. PAN Biotech Recent Developments
  • Table 88. PromoCell Company Information
  • Table 89. PromoCell Business Overview
  • Table 90. PromoCell Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 91. PromoCell Cell Freezing Media Product Portfolio
  • Table 92. PromoCell Recent Developments
  • Table 93. MP Biomedicals Company Information
  • Table 94. MP Biomedicals Business Overview
  • Table 95. MP Biomedicals Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 96. MP Biomedicals Cell Freezing Media Product Portfolio
  • Table 97. MP Biomedicals Recent Developments
  • Table 98. ATCC Company Information
  • Table 99. ATCC Business Overview
  • Table 100. ATCC Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 101. ATCC Cell Freezing Media Product Portfolio
  • Table 102. ATCC Recent Developments
  • Table 103. Teknova Company Information
  • Table 104. Teknova Business Overview
  • Table 105. Teknova Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 106. Teknova Cell Freezing Media Product Portfolio
  • Table 107. Teknova Recent Developments
  • Table 108. Yocon Biotechnology Company Information
  • Table 109. Yocon Biotechnology Business Overview
  • Table 110. Yocon Biotechnology Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 111. Yocon Biotechnology Cell Freezing Media Product Portfolio
  • Table 112. Yocon Biotechnology Recent Developments
  • Table 113. ExCell Bio Company Information
  • Table 114. ExCell Bio Business Overview
  • Table 115. ExCell Bio Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 116. ExCell Bio Cell Freezing Media Product Portfolio
  • Table 117. ExCell Bio Recent Developments
  • Table 118. Shanghai BasalMedia Company Information
  • Table 119. Shanghai BasalMedia Business Overview
  • Table 120. Shanghai BasalMedia Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 121. Shanghai BasalMedia Cell Freezing Media Product Portfolio
  • Table 122. Shanghai BasalMedia Recent Developments
  • Table 123. Dakewe Company Information
  • Table 124. Dakewe Business Overview
  • Table 125. Dakewe Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 126. Dakewe Cell Freezing Media Product Portfolio
  • Table 127. Dakewe Recent Developments
  • Table 128. Cyagen Biosciences Company Information
  • Table 129. Cyagen Biosciences Business Overview
  • Table 130. Cyagen Biosciences Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 131. Cyagen Biosciences Cell Freezing Media Product Portfolio
  • Table 132. Cyagen Biosciences Recent Developments
  • Table 133. Yeasen Biotechnology Company Information
  • Table 134. Yeasen Biotechnology Business Overview
  • Table 135. Yeasen Biotechnology Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 136. Yeasen Biotechnology Cell Freezing Media Product Portfolio
  • Table 137. Yeasen Biotechnology Recent Developments
  • Table 138. Solarbio Company Information
  • Table 139. Solarbio Business Overview
  • Table 140. Solarbio Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 141. Solarbio Cell Freezing Media Product Portfolio
  • Table 142. Solarbio Recent Developments
  • Table 143. Beyotime Biotechnology Company Information
  • Table 144. Beyotime Biotechnology Business Overview
  • Table 145. Beyotime Biotechnology Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 146. Beyotime Biotechnology Cell Freezing Media Product Portfolio
  • Table 147. Beyotime Biotechnology Recent Developments
  • Table 148. Quality Biological Company Information
  • Table 149. Quality Biological Business Overview
  • Table 150. Quality Biological Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 151. Quality Biological Cell Freezing Media Product Portfolio
  • Table 152. Quality Biological Recent Developments
  • Table 153. WELGENE Company Information
  • Table 154. WELGENE Business Overview
  • Table 155. WELGENE Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 156. WELGENE Cell Freezing Media Product Portfolio
  • Table 157. WELGENE Recent Developments
  • Table 158. GC Lymphotec Company Information
  • Table 159. GC Lymphotec Business Overview
  • Table 160. GC Lymphotec Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 161. GC Lymphotec Cell Freezing Media Product Portfolio
  • Table 162. GC Lymphotec Recent Developments
  • Table 163. Capricorn Scientific Company Information
  • Table 164. Capricorn Scientific Business Overview
  • Table 165. Capricorn Scientific Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 166. Capricorn Scientific Cell Freezing Media Product Portfolio
  • Table 167. Capricorn Scientific Recent Developments
  • Table 168. Meilun Biotechnology Company Information
  • Table 169. Meilun Biotechnology Business Overview
  • Table 170. Meilun Biotechnology Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 171. Meilun Biotechnology Cell Freezing Media Product Portfolio
  • Table 172. Meilun Biotechnology Recent Developments
  • Table 173. Nacalai Tesque Company Information
  • Table 174. Nacalai Tesque Business Overview
  • Table 175. Nacalai Tesque Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 176. Nacalai Tesque Cell Freezing Media Product Portfolio
  • Table 177. Nacalai Tesque Recent Developments
  • Table 178. Saraya Company Information
  • Table 179. Saraya Business Overview
  • Table 180. Saraya Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 181. Saraya Cell Freezing Media Product Portfolio
  • Table 182. Saraya Recent Developments
  • Table 183. ScienCell Research Laboratories Company Information
  • Table 184. ScienCell Research Laboratories Business Overview
  • Table 185. ScienCell Research Laboratories Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 186. ScienCell Research Laboratories Cell Freezing Media Product Portfolio
  • Table 187. ScienCell Research Laboratories Recent Developments
  • Table 188. Cell Applications Company Information
  • Table 189. Cell Applications Business Overview
  • Table 190. Cell Applications Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 191. Cell Applications Cell Freezing Media Product Portfolio
  • Table 192. Cell Applications Recent Developments
  • Table 193. Nanjing Sansheng Biotechnology Company Information
  • Table 194. Nanjing Sansheng Biotechnology Business Overview
  • Table 195. Nanjing Sansheng Biotechnology Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 196. Nanjing Sansheng Biotechnology Cell Freezing Media Product Portfolio
  • Table 197. Nanjing Sansheng Biotechnology Recent Developments
  • Table 198. Pricella Biotechnology Company Information
  • Table 199. Pricella Biotechnology Business Overview
  • Table 200. Pricella Biotechnology Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 201. Pricella Biotechnology Cell Freezing Media Product Portfolio
  • Table 202. Pricella Biotechnology Recent Developments
  • Table 203. CELLnTEC Company Information
  • Table 204. CELLnTEC Business Overview
  • Table 205. CELLnTEC Cell Freezing Media Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
  • Table 206. CELLnTEC Cell Freezing Media Product Portfolio
  • Table 207. CELLnTEC Recent Developments
  • Table 208. Global Cell Freezing Media Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
  • Table 209. Global Cell Freezing Media Sales by Region (2021-2026) & (L)
  • Table 210. Global Cell Freezing Media Sales Market Share by Region (2021-2026)
  • Table 211. Global Cell Freezing Media Sales by Region (2027-2032) & (L)
  • Table 212. Global Cell Freezing Media Sales Market Share by Region (2027-2032)
  • Table 213. Global Cell Freezing Media Revenue by Region (2021-2026) & (US$ Million)
  • Table 214. Global Cell Freezing Media Revenue Market Share by Region (2021-2026)
  • Table 215. Global Cell Freezing Media Revenue by Region (2027-2032) & (US$ Million)
  • Table 216. Global Cell Freezing Media Revenue Market Share by Region (2027-2032)
  • Table 217. North America Cell Freezing Media Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 218. North America Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 219. North America Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 220. North America Cell Freezing Media Revenue by Country (2021-2026) & (US$ Million)
  • Table 221. North America Cell Freezing Media Revenue by Country (2027-2032) & (US$ Million)
  • Table 222. Europe Cell Freezing Media Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 223. Europe Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 224. Europe Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 225. Europe Cell Freezing Media Revenue by Country (2021-2026) & (US$ Million)
  • Table 226. Europe Cell Freezing Media Revenue by Country (2027-2032) & (US$ Million)
  • Table 227. Asia Pacific Cell Freezing Media Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 228. Asia Pacific Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 229. Asia Pacific Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 230. Asia Pacific Cell Freezing Media Revenue by Country (2021-2026) & (US$ Million)
  • Table 231. Asia Pacific Cell Freezing Media Revenue by Country (2027-2032) & (US$ Million)
  • Table 232. South America Cell Freezing Media Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 233. South America Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 234. South America Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 235. South America Cell Freezing Media Revenue by Country (2021-2026) & (US$ Million)
  • Table 236. South America Cell Freezing Media Revenue by Country (2027-2032) & (US$ Million)
  • Table 237. Middle East and Africa Cell Freezing Media Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
  • Table 238. Middle East and Africa Cell Freezing Media Sales by Country (2021-2026) & (L)
  • Table 239. Middle East and Africa Cell Freezing Media Sales by Country (2027-2032) & (L)
  • Table 240. Middle East and Africa Cell Freezing Media Revenue by Country (2021-2026) & (US$ Million)
  • Table 241. Middle East and Africa Cell Freezing Media Revenue by Country (2027-2032) & (US$ Million)
  • Table 242. Global Cell Freezing Media Sales by Type (2021-2026) & (L)
  • Table 243. Global Cell Freezing Media Sales by Type (2027-2032) & (L)
  • Table 244. Global Cell Freezing Media Sales Market Share by Type (2021-2026)
  • Table 245. Global Cell Freezing Media Sales Market Share by Type (2027-2032)
  • Table 246. Global Cell Freezing Media Revenue by Type (2021-2026) & (US$ Million)
  • Table 247. Global Cell Freezing Media Revenue by Type (2027-2032) & (US$ Million)
  • Table 248. Global Cell Freezing Media Revenue Market Share by Type (2021-2026)
  • Table 249. Global Cell Freezing Media Revenue Market Share by Type (2027-2032)
  • Table 250. Global Cell Freezing Media Price by Type (2021-2026) & (USD/L)
  • Table 251. Global Cell Freezing Media Price by Type (2027-2032) & (USD/L)
  • Table 252. Global Cell Freezing Media Sales by Application (2021-2026) & (L)
  • Table 253. Global Cell Freezing Media Sales by Application (2027-2032) & (L)
  • Table 254. Global Cell Freezing Media Sales Market Share by Application (2021-2026)
  • Table 255. Global Cell Freezing Media Sales Market Share by Application (2027-2032)
  • Table 256. Global Cell Freezing Media Revenue by Application (2021-2026) & (US$ Million)
  • Table 257. Global Cell Freezing Media Revenue by Application (2027-2032) & (US$ Million)
  • Table 258. Global Cell Freezing Media Revenue Market Share by Application (2021-2026)
  • Table 259. Global Cell Freezing Media Revenue Market Share by Application (2027-2032)
  • Table 260. Global Cell Freezing Media Price by Application (2021-2026) & (USD/L)
  • Table 261. Global Cell Freezing Media Price by Application (2027-2032) & (USD/L)
  • Table 262. Key Raw Materials
  • Table 263. Raw Materials Key Suppliers
  • Table 264. Cell Freezing Media Distributors List
  • Table 265. Cell Freezing Media Customers List
  • Table 266. Cell Freezing Media Industry Trends
  • Table 267. Cell Freezing Media Industry Drivers
  • Table 268. Cell Freezing Media Industry Restraints
  • Table 269. Authors List of This Report

List of Figures

  • Figure 1. Research Methodology
  • Figure 2. Research Process
  • Figure 3. Key Executives Interviewed
  • Figure 4. Cell Freezing Media Product Image
  • Figure 5. Global Cell Freezing Media Revenue (US$ Million), 2021 VS 2025 VS 2032
  • Figure 6. Global Cell Freezing Media Market Size (2021-2032) & (US$ Million)
  • Figure 7. Global Cell Freezing Media Sales (2021-2032) & (L)
  • Figure 8. Global Cell Freezing Media Average Price (USD/L) & (2021-2032)
  • Figure 9. DMSO Containing Product Image
  • Figure 10. DMSO Free Product Image
  • Figure 11. Research Product Image
  • Figure 12. Biobanking Product Image
  • Figure 13. Biopharmaceutical Manufacturing Product Image
  • Figure 14. Cell Therapy and Regenerative Medicine Product Image
  • Figure 15. Global Cell Freezing Media Revenue Share by Manufacturers in 2025
  • Figure 16. Global Manufacturers of Cell Freezing Media, Manufacturing Sites & Headquarters
  • Figure 17. Global Top 5 and 10 Cell Freezing Media Players Market Share by Revenue in 2025
  • Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
  • Figure 19. Global Cell Freezing Media Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
  • Figure 20. Global Cell Freezing Media Sales by Region in 2025
  • Figure 21. Global Cell Freezing Media Revenue by Region in 2025
  • Figure 22. North America Cell Freezing Media Market Size by Country in 2025
  • Figure 23. North America Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 24. North America Cell Freezing Media Revenue Market Share by Country (2021-2032)
  • Figure 25. United States Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 26. Canada Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 27. Mexico Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 28. Europe Cell Freezing Media Market Size by Country in 2025
  • Figure 29. Europe Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 30. Europe Cell Freezing Media Revenue Market Share by Country (2021-2032)
  • Figure 31. Germany Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 32. France Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 33. U.K. Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 34. Italy Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 35. Russia Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 36. Spain Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 37. Netherlands Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 38. Switzerland Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 39. Sweden Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 40. Poland Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 41. Asia Pacific Cell Freezing Media Market Size by Country in 2025
  • Figure 42. Asia Pacific Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 43. Asia Pacific Cell Freezing Media Revenue Market Share by Country (2021-2032)
  • Figure 44. China Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 45. Japan Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 46. South Korea Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 47. India Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 48. Australia Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 49. Taiwan Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 50. Southeast Asia Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 51. Southeast Asia Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 52. South America Cell Freezing Media Market Size by Country in 2025
  • Figure 53. South America Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 54. South America Cell Freezing Media Revenue Market Share by Country (2021-2032)
  • Figure 55. Brazil Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 56. Argentina Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 57. Chile Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 58. Colombia Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 59. Middle East and Africa Cell Freezing Media Market Size by Country in 2025
  • Figure 60. Middle East and Africa Cell Freezing Media Sales Market Share by Country (2021-2032)
  • Figure 61. Middle East and Africa Cell Freezing Media Revenue Market Share by Country (2021-2032)
  • Figure 62. Egypt Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 63. South Africa Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 64. Israel Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 65. Türkiye Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 66. GCC Countries Cell Freezing Media Revenue Growth Rate (2021-2032) & (US$ Million)
  • Figure 67. Global Cell Freezing Media Sales Market Share by Type (2021-2032)
  • Figure 68. Global Cell Freezing Media Revenue Market Share by Type (2021-2032)
  • Figure 69. Global Cell Freezing Media Price (USD/L) by Type (2021-2032)
  • Figure 70. Global Cell Freezing Media Sales Market Share by Application (2021-2032)
  • Figure 71. Global Cell Freezing Media Revenue Market Share by Application (2021-2032)
  • Figure 72. Global Cell Freezing Media Price (USD/L) by Application (2021-2032)
  • Figure 73. Cell Freezing Media Value Chain
  • Figure 74. Cell Freezing Media Production Mode & Process
  • Figure 75. Direct Comparison with Distribution Share
  • Figure 76. Distributors Profiles
  • Figure 77. Cell Freezing Media Industry Opportunities and Challenges

Scope & coverage.

By Type
  • DMSO Containing
  • DMSO Free
By Application
  • Research
  • Biobanking
  • Biopharmaceutical Manufacturing
  • Cell Therapy and Regenerative Medicine
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Cytiva
  • Sartorius
  • FUJIFILM
  • BioLife Solutions
  • Lonza
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Bio Techne
  • Avantor
  • HiMedia Laboratories
  • ZENOAQ
  • PAN Biotech
  • PromoCell
  • MP Biomedicals
  • ATCC
  • Teknova
  • Yocon Biotechnology
  • ExCell Bio
  • Shanghai BasalMedia
  • Dakewe
  • Cyagen Biosciences
  • Yeasen Biotechnology
  • Solarbio
  • Beyotime Biotechnology
  • Quality Biological
  • WELGENE
  • GC Lymphotec
  • Capricorn Scientific
  • Meilun Biotechnology
  • Nacalai Tesque
  • Saraya
  • ScienCell Research Laboratories
  • Cell Applications
  • Nanjing Sansheng Biotechnology
  • Pricella Biotechnology
  • CELLnTEC

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cell Freezing Media Market Size (2021-2032)
  4. 2.2.2 Global Cell Freezing Media Sales (2021-2032)
  5. 2.2.3 Global Cell Freezing Media Market Average Price (2021-2032)
  6. 2.3 Cell Freezing Media by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 DMSO Containing
  9. 2.3.3 DMSO Free
  10. 2.4 Cell Freezing Media by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Research
  13. 2.4.3 Biobanking
  14. 2.4.4 Biopharmaceutical Manufacturing
  15. 2.4.5 Cell Therapy and Regenerative Medicine
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cell Freezing Media Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cell Freezing Media Sales (L) of Manufacturers (2021-2026)
  3. 3.3 Global Cell Freezing Media Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cell Freezing Media Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cell Freezing Media Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cell Freezing Media, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cell Freezing Media, Product Type & Application
  8. 3.8 Global Manufacturers of Cell Freezing Media, Established Date
  9. 3.9 Global Cell Freezing Media Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Thermo Fisher Scientific
  2. 4.1.1 Thermo Fisher Scientific Company Information
  3. 4.1.2 Thermo Fisher Scientific Business Overview
  4. 4.1.3 Thermo Fisher Scientific Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Thermo Fisher Scientific Cell Freezing Media Product Portfolio
  6. 4.1.5 Thermo Fisher Scientific Recent Developments
  7. 4.2 Merck
  8. 4.2.1 Merck Company Information
  9. 4.2.2 Merck Business Overview
  10. 4.2.3 Merck Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck Cell Freezing Media Product Portfolio
  12. 4.2.5 Merck Recent Developments
  13. 4.3 Cytiva
  14. 4.3.1 Cytiva Company Information
  15. 4.3.2 Cytiva Business Overview
  16. 4.3.3 Cytiva Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Cytiva Cell Freezing Media Product Portfolio
  18. 4.3.5 Cytiva Recent Developments
  19. 4.4 Sartorius
  20. 4.4.1 Sartorius Company Information
  21. 4.4.2 Sartorius Business Overview
  22. 4.4.3 Sartorius Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sartorius Cell Freezing Media Product Portfolio
  24. 4.4.5 Sartorius Recent Developments
  25. 4.5 FUJIFILM
  26. 4.5.1 FUJIFILM Company Information
  27. 4.5.2 FUJIFILM Business Overview
  28. 4.5.3 FUJIFILM Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 FUJIFILM Cell Freezing Media Product Portfolio
  30. 4.5.5 FUJIFILM Recent Developments
  31. 4.6 BioLife Solutions
  32. 4.6.1 BioLife Solutions Company Information
  33. 4.6.2 BioLife Solutions Business Overview
  34. 4.6.3 BioLife Solutions Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 BioLife Solutions Cell Freezing Media Product Portfolio
  36. 4.6.5 BioLife Solutions Recent Developments
  37. 4.7 Lonza
  38. 4.7.1 Lonza Company Information
  39. 4.7.2 Lonza Business Overview
  40. 4.7.3 Lonza Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Lonza Cell Freezing Media Product Portfolio
  42. 4.7.5 Lonza Recent Developments
  43. 4.8 STEMCELL Technologies
  44. 4.8.1 STEMCELL Technologies Company Information
  45. 4.8.2 STEMCELL Technologies Business Overview
  46. 4.8.3 STEMCELL Technologies Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 STEMCELL Technologies Cell Freezing Media Product Portfolio
  48. 4.8.5 STEMCELL Technologies Recent Developments
  49. 4.9 Miltenyi Biotec
  50. 4.9.1 Miltenyi Biotec Company Information
  51. 4.9.2 Miltenyi Biotec Business Overview
  52. 4.9.3 Miltenyi Biotec Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Miltenyi Biotec Cell Freezing Media Product Portfolio
  54. 4.9.5 Miltenyi Biotec Recent Developments
  55. 4.10 Bio Techne
  56. 4.10.1 Bio Techne Company Information
  57. 4.10.2 Bio Techne Business Overview
  58. 4.10.3 Bio Techne Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bio Techne Cell Freezing Media Product Portfolio
  60. 4.10.5 Bio Techne Recent Developments
  61. 4.11 Avantor
  62. 4.11.1 Avantor Company Information
  63. 4.11.2 Avantor Business Overview
  64. 4.11.3 Avantor Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Avantor Cell Freezing Media Product Portfolio
  66. 4.11.5 Avantor Recent Developments
  67. 4.12 HiMedia Laboratories
  68. 4.12.1 HiMedia Laboratories Company Information
  69. 4.12.2 HiMedia Laboratories Business Overview
  70. 4.12.3 HiMedia Laboratories Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 HiMedia Laboratories Cell Freezing Media Product Portfolio
  72. 4.12.5 HiMedia Laboratories Recent Developments
  73. 4.13 ZENOAQ
  74. 4.13.1 ZENOAQ Company Information
  75. 4.13.2 ZENOAQ Business Overview
  76. 4.13.3 ZENOAQ Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 ZENOAQ Cell Freezing Media Product Portfolio
  78. 4.13.5 ZENOAQ Recent Developments
  79. 4.14 PAN Biotech
  80. 4.14.1 PAN Biotech Company Information
  81. 4.14.2 PAN Biotech Business Overview
  82. 4.14.3 PAN Biotech Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 PAN Biotech Cell Freezing Media Product Portfolio
  84. 4.14.5 PAN Biotech Recent Developments
  85. 4.15 PromoCell
  86. 4.15.1 PromoCell Company Information
  87. 4.15.2 PromoCell Business Overview
  88. 4.15.3 PromoCell Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 PromoCell Cell Freezing Media Product Portfolio
  90. 4.15.5 PromoCell Recent Developments
  91. 4.16 MP Biomedicals
  92. 4.16.1 MP Biomedicals Company Information
  93. 4.16.2 MP Biomedicals Business Overview
  94. 4.16.3 MP Biomedicals Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 MP Biomedicals Cell Freezing Media Product Portfolio
  96. 4.16.5 MP Biomedicals Recent Developments
  97. 4.17 ATCC
  98. 4.17.1 ATCC Company Information
  99. 4.17.2 ATCC Business Overview
  100. 4.17.3 ATCC Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 ATCC Cell Freezing Media Product Portfolio
  102. 4.17.5 ATCC Recent Developments
  103. 4.18 Teknova
  104. 4.18.1 Teknova Company Information
  105. 4.18.2 Teknova Business Overview
  106. 4.18.3 Teknova Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Teknova Cell Freezing Media Product Portfolio
  108. 4.18.5 Teknova Recent Developments
  109. 4.19 Yocon Biotechnology
  110. 4.19.1 Yocon Biotechnology Company Information
  111. 4.19.2 Yocon Biotechnology Business Overview
  112. 4.19.3 Yocon Biotechnology Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Yocon Biotechnology Cell Freezing Media Product Portfolio
  114. 4.19.5 Yocon Biotechnology Recent Developments
  115. 4.20 ExCell Bio
  116. 4.20.1 ExCell Bio Company Information
  117. 4.20.2 ExCell Bio Business Overview
  118. 4.20.3 ExCell Bio Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 ExCell Bio Cell Freezing Media Product Portfolio
  120. 4.20.5 ExCell Bio Recent Developments
  121. 4.21 Shanghai BasalMedia
  122. 4.21.1 Shanghai BasalMedia Company Information
  123. 4.21.2 Shanghai BasalMedia Business Overview
  124. 4.21.3 Shanghai BasalMedia Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Shanghai BasalMedia Cell Freezing Media Product Portfolio
  126. 4.21.5 Shanghai BasalMedia Recent Developments
  127. 4.22 Dakewe
  128. 4.22.1 Dakewe Company Information
  129. 4.22.2 Dakewe Business Overview
  130. 4.22.3 Dakewe Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Dakewe Cell Freezing Media Product Portfolio
  132. 4.22.5 Dakewe Recent Developments
  133. 4.23 Cyagen Biosciences
  134. 4.23.1 Cyagen Biosciences Company Information
  135. 4.23.2 Cyagen Biosciences Business Overview
  136. 4.23.3 Cyagen Biosciences Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Cyagen Biosciences Cell Freezing Media Product Portfolio
  138. 4.23.5 Cyagen Biosciences Recent Developments
  139. 4.24 Yeasen Biotechnology
  140. 4.24.1 Yeasen Biotechnology Company Information
  141. 4.24.2 Yeasen Biotechnology Business Overview
  142. 4.24.3 Yeasen Biotechnology Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Yeasen Biotechnology Cell Freezing Media Product Portfolio
  144. 4.24.5 Yeasen Biotechnology Recent Developments
  145. 4.25 Solarbio
  146. 4.25.1 Solarbio Company Information
  147. 4.25.2 Solarbio Business Overview
  148. 4.25.3 Solarbio Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Solarbio Cell Freezing Media Product Portfolio
  150. 4.25.5 Solarbio Recent Developments
  151. 4.26 Beyotime Biotechnology
  152. 4.26.1 Beyotime Biotechnology Company Information
  153. 4.26.2 Beyotime Biotechnology Business Overview
  154. 4.26.3 Beyotime Biotechnology Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Beyotime Biotechnology Cell Freezing Media Product Portfolio
  156. 4.26.5 Beyotime Biotechnology Recent Developments
  157. 4.27 Quality Biological
  158. 4.27.1 Quality Biological Company Information
  159. 4.27.2 Quality Biological Business Overview
  160. 4.27.3 Quality Biological Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 Quality Biological Cell Freezing Media Product Portfolio
  162. 4.27.5 Quality Biological Recent Developments
  163. 4.28 WELGENE
  164. 4.28.1 WELGENE Company Information
  165. 4.28.2 WELGENE Business Overview
  166. 4.28.3 WELGENE Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 WELGENE Cell Freezing Media Product Portfolio
  168. 4.28.5 WELGENE Recent Developments
  169. 4.29 GC Lymphotec
  170. 4.29.1 GC Lymphotec Company Information
  171. 4.29.2 GC Lymphotec Business Overview
  172. 4.29.3 GC Lymphotec Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  173. 4.29.4 GC Lymphotec Cell Freezing Media Product Portfolio
  174. 4.29.5 GC Lymphotec Recent Developments
  175. 4.30 Capricorn Scientific
  176. 4.30.1 Capricorn Scientific Company Information
  177. 4.30.2 Capricorn Scientific Business Overview
  178. 4.30.3 Capricorn Scientific Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  179. 4.30.4 Capricorn Scientific Cell Freezing Media Product Portfolio
  180. 4.30.5 Capricorn Scientific Recent Developments
  181. 4.31 Meilun Biotechnology
  182. 4.31.1 Meilun Biotechnology Company Information
  183. 4.31.2 Meilun Biotechnology Business Overview
  184. 4.31.3 Meilun Biotechnology Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  185. 4.31.4 Meilun Biotechnology Cell Freezing Media Product Portfolio
  186. 4.31.5 Meilun Biotechnology Recent Developments
  187. 4.32 Nacalai Tesque
  188. 4.32.1 Nacalai Tesque Company Information
  189. 4.32.2 Nacalai Tesque Business Overview
  190. 4.32.3 Nacalai Tesque Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  191. 4.32.4 Nacalai Tesque Cell Freezing Media Product Portfolio
  192. 4.32.5 Nacalai Tesque Recent Developments
  193. 4.33 Saraya
  194. 4.33.1 Saraya Company Information
  195. 4.33.2 Saraya Business Overview
  196. 4.33.3 Saraya Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  197. 4.33.4 Saraya Cell Freezing Media Product Portfolio
  198. 4.33.5 Saraya Recent Developments
  199. 4.34 ScienCell Research Laboratories
  200. 4.34.1 ScienCell Research Laboratories Company Information
  201. 4.34.2 ScienCell Research Laboratories Business Overview
  202. 4.34.3 ScienCell Research Laboratories Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  203. 4.34.4 ScienCell Research Laboratories Cell Freezing Media Product Portfolio
  204. 4.34.5 ScienCell Research Laboratories Recent Developments
  205. 4.35 Cell Applications
  206. 4.35.1 Cell Applications Company Information
  207. 4.35.2 Cell Applications Business Overview
  208. 4.35.3 Cell Applications Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  209. 4.35.4 Cell Applications Cell Freezing Media Product Portfolio
  210. 4.35.5 Cell Applications Recent Developments
  211. 4.36 Nanjing Sansheng Biotechnology
  212. 4.36.1 Nanjing Sansheng Biotechnology Company Information
  213. 4.36.2 Nanjing Sansheng Biotechnology Business Overview
  214. 4.36.3 Nanjing Sansheng Biotechnology Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  215. 4.36.4 Nanjing Sansheng Biotechnology Cell Freezing Media Product Portfolio
  216. 4.36.5 Nanjing Sansheng Biotechnology Recent Developments
  217. 4.37 Pricella Biotechnology
  218. 4.37.1 Pricella Biotechnology Company Information
  219. 4.37.2 Pricella Biotechnology Business Overview
  220. 4.37.3 Pricella Biotechnology Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  221. 4.37.4 Pricella Biotechnology Cell Freezing Media Product Portfolio
  222. 4.37.5 Pricella Biotechnology Recent Developments
  223. 4.38 CELLnTEC
  224. 4.38.1 CELLnTEC Company Information
  225. 4.38.2 CELLnTEC Business Overview
  226. 4.38.3 CELLnTEC Cell Freezing Media Sales, Revenue and Gross Margin (2021-2026)
  227. 4.38.4 CELLnTEC Cell Freezing Media Product Portfolio
  228. 4.38.5 CELLnTEC Recent Developments
5 Global Cell Freezing Media Market Scenario by Region
  1. 5.1 Global Cell Freezing Media Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cell Freezing Media Sales by Region: 2021-2032
  3. 5.2.1 Global Cell Freezing Media Sales by Region: 2021-2026
  4. 5.2.2 Global Cell Freezing Media Sales by Region: 2027-2032
  5. 5.3 Global Cell Freezing Media Revenue by Region: 2021-2032
  6. 5.3.1 Global Cell Freezing Media Revenue by Region: 2021-2026
  7. 5.3.2 Global Cell Freezing Media Revenue by Region: 2027-2032
  8. 5.4 North America Cell Freezing Media Market Facts & Figures by Country
  9. 5.4.1 North America Cell Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cell Freezing Media Sales by Country (2021-2032)
  11. 5.4.3 North America Cell Freezing Media Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cell Freezing Media Market Facts & Figures by Country
  16. 5.5.1 Europe Cell Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cell Freezing Media Sales by Country (2021-2032)
  18. 5.5.3 Europe Cell Freezing Media Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cell Freezing Media Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cell Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cell Freezing Media Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cell Freezing Media Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cell Freezing Media Market Facts & Figures by Country
  41. 5.7.1 South America Cell Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cell Freezing Media Sales by Country (2021-2032)
  43. 5.7.3 South America Cell Freezing Media Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Cell Freezing Media Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Cell Freezing Media Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Cell Freezing Media Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Cell Freezing Media Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cell Freezing Media Sales by Type (2021-2032)
  2. 6.1.1 Global Cell Freezing Media Sales by Type (2021-2032) & (L)
  3. 6.1.2 Global Cell Freezing Media Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cell Freezing Media Revenue by Type (2021-2032)
  5. 6.2.1 Global Cell Freezing Media Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cell Freezing Media Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cell Freezing Media Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cell Freezing Media Sales by Application (2021-2032)
  2. 7.1.1 Global Cell Freezing Media Sales by Application (2021-2032) & (L)
  3. 7.1.2 Global Cell Freezing Media Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cell Freezing Media Revenue by Application (2021-2032)
  5. 7.2.1 Global Cell Freezing Media Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cell Freezing Media Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cell Freezing Media Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cell Freezing Media Value Chain Analysis
  2. 8.1.1 Cell Freezing Media Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cell Freezing Media Production Mode & Process
  5. 8.2 Cell Freezing Media Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cell Freezing Media Distributors
  8. 8.2.3 Cell Freezing Media Customers
9 Global Cell Freezing Media Analyzing Market Dynamics
  1. 9.1 Cell Freezing Media Industry Trends
  2. 9.2 Cell Freezing Media Industry Drivers
  3. 9.3 Cell Freezing Media Industry Opportunities and Challenges
  4. 9.4 Cell Freezing Media Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.